Literature DB >> 24469401

Yin Yang 1 is a repressor of glutamate transporter EAAT2, and it mediates manganese-induced decrease of EAAT2 expression in astrocytes.

Pratap Karki1, Anton Webb, Keisha Smith, James Johnson, Kyuwon Lee, Deok-Soo Son, Michael Aschner, Eunsook Lee.   

Abstract

Impairment of astrocytic glutamate transporter (GLT-1; EAAT2) function is associated with multiple neurodegenerative diseases, including Parkinson's disease (PD) and manganism, the latter being induced by chronic exposure to high levels of manganese (Mn). Mn decreases EAAT2 promoter activity and mRNA and protein levels, but the molecular mechanism of Mn-induced EAAT2 repression at the transcriptional level has yet to be elucidated. We reveal that transcription factor Yin Yang 1 (YY1) is critical in repressing EAAT2 and mediates the effects of negative regulators, such as Mn and tumor necrosis factor alpha (TNF-α), on EAAT2. YY1 overexpression in astrocytes reduced EAAT2 promoter activity, while YY1 knockdown or mutation of the YY1 consensus site of the EAAT2 promoter increased its promoter activity and attenuated the Mn-induced repression of EAAT2. Mn increased YY1 promoter activity and mRNA and protein levels via NF-κB activation. This led to increased YY1 binding to the EAAT2 promoter region. Epigenetically, histone deacetylase (HDAC) classes I and II served as corepressors of YY1, and, accordingly, HDAC inhibitors increased EAAT2 promoter activity and reversed the Mn-induced repression of EAAT2 promoter activity. Taken together, our findings suggest that YY1, with HDACs as corepressors, is a critical negative transcriptional regulator of EAAT2 and mediates Mn-induced EAAT2 repression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24469401      PMCID: PMC3993574          DOI: 10.1128/MCB.01176-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

Review 1.  Role of manganese in neurodegenerative diseases.

Authors:  Aaron B Bowman; Gunnar F Kwakye; Elena Herrero Hernández; Michael Aschner
Journal:  J Trace Elem Med Biol       Date:  2011-10-01       Impact factor: 3.849

Review 2.  Neuroinflammation and synaptic loss.

Authors:  Jagadeesh S Rao; Matthew Kellom; Hyung-Wook Kim; Stanley I Rapoport; Edmund A Reese
Journal:  Neurochem Res       Date:  2012-02-07       Impact factor: 3.996

3.  Histone deacetylase inhibitors preserve white matter structure and function during ischemia by conserving ATP and reducing excitotoxicity.

Authors:  Selva Baltan; Sean P Murphy; Camelia A Danilov; Amelia Bachleda; Richard S Morrison
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

Review 4.  Yin Yang 1 in human cancer.

Authors:  Sarah Nicholson; Helen Whitehouse; Khimara Naidoo; Richard J Byers
Journal:  Crit Rev Oncog       Date:  2011

5.  Oncogene AEG-1 promotes glioma-induced neurodegeneration by increasing glutamate excitotoxicity.

Authors:  Seok-Geun Lee; Keetae Kim; Timothy P Kegelman; Rupesh Dash; Swadesh K Das; Jung Kyoung Choi; Luni Emdad; Eric L Howlett; Hyun Yong Jeon; Zhao Zhong Su; Byoung Kwon Yoo; Devanand Sarkar; Sung-Hoon Kim; Dong-Chul Kang; Paul B Fisher
Journal:  Cancer Res       Date:  2011-08-18       Impact factor: 12.701

Review 6.  Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.

Authors:  Keetae Kim; Seok-Geun Lee; Timothy P Kegelman; Zhao-Zhong Su; Swadesh K Das; Rupesh Dash; Santanu Dasgupta; Paola M Barral; Michael Hedvat; Paul Diaz; John C Reed; John L Stebbins; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  J Cell Physiol       Date:  2011-10       Impact factor: 6.384

Review 7.  Yin Yang 1: a multifaceted protein beyond a transcription factor.

Authors:  Zhiyong Deng; Paul Cao; Mei Mei Wan; Guangchao Sui
Journal:  Transcription       Date:  2010 Sep-Oct

8.  Estrogen and tamoxifen reverse manganese-induced glutamate transporter impairment in astrocytes.

Authors:  Eun-Sook Y Lee; Marta Sidoryk; Haiyan Jiang; Zhaobao Yin; Michael Aschner
Journal:  J Neurochem       Date:  2009-04-22       Impact factor: 5.372

9.  Manganese disrupts astrocyte glutamine transporter expression and function.

Authors:  Marta Sidoryk-Wegrzynowicz; Eunsook Lee; Jan Albrecht; Michael Aschner
Journal:  J Neurochem       Date:  2009-05-15       Impact factor: 5.372

10.  Epigenetic regulation of neuron-dependent induction of astroglial synaptic protein GLT1.

Authors:  Yongjie Yang; Oguz Gozen; Svetlana Vidensky; Michael B Robinson; Jeffrey D Rothstein
Journal:  Glia       Date:  2010-02       Impact factor: 7.452

View more
  42 in total

1.  Valproate and sodium butyrate attenuate manganese-decreased locomotor activity and astrocytic glutamate transporters expression in mice.

Authors:  James Johnson; Edward Alain B Pajarillo; Equar Taka; Romonia Reams; Deok-Soo Son; Michael Aschner; Eunsook Lee
Journal:  Neurotoxicology       Date:  2017-06-10       Impact factor: 4.294

2.  Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid transporter-2 repression.

Authors:  Neha Vartak-Sharma; Benjamin B Gelman; Chaitanya Joshi; Kathleen Borgamann; Anuja Ghorpade
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

Review 3.  Neurotoxicity Linked to Dysfunctional Metal Ion Homeostasis and Xenobiotic Metal Exposure: Redox Signaling and Oxidative Stress.

Authors:  Carla Garza-Lombó; Yanahi Posadas; Liliana Quintanar; María E Gonsebatt; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2018-03-28       Impact factor: 8.401

Review 4.  Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms.

Authors:  Arthi Kanthasamy; Huajun Jin; Adhithiya Charli; Anantharam Vellareddy; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

Review 5.  Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.

Authors:  Kou Takahashi; Joshua B Foster; Chien-Liang Glenn Lin
Journal:  Cell Mol Life Sci       Date:  2015-06-02       Impact factor: 9.261

Review 6.  Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicity.

Authors:  Pratap Karki; Keisha Smith; James Johnson; Michael Aschner; Eunsook Y Lee
Journal:  Neurochem Res       Date:  2014-07-27       Impact factor: 3.996

Review 7.  Role of transcription factor yin yang 1 in manganese-induced reduction of astrocytic glutamate transporters: Putative mechanism for manganese-induced neurotoxicity.

Authors:  Pratap Karki; Keisha Smith; James Johnson; Michael Aschner; Eunsook Lee
Journal:  Neurochem Int       Date:  2014-08-13       Impact factor: 3.921

8.  Mechanism of raloxifene-induced upregulation of glutamate transporters in rat primary astrocytes.

Authors:  Pratap Karki; Anton Webb; Abdelbassat Zerguine; Joseph Choi; Deok-Soo Son; Eunsook Lee
Journal:  Glia       Date:  2014-04-29       Impact factor: 7.452

9.  Huntington's disease genotype suppresses global manganese-responsive processes in pre-manifest and manifest YAC128 mice.

Authors:  Anna C Pfalzer; Jordyn M Wilcox; Simona G Codreanu; Melissa Totten; Terry J V Bichell; Timothy Halbesma; Preethi Umashanker; Kevin L Yang; Nancy L Parmalee; Stacy D Sherrod; Keith M Erikson; Fiona E Harrison; John A McLean; Michael Aschner; Aaron B Bowman
Journal:  Metallomics       Date:  2020-07-22       Impact factor: 4.526

Review 10.  Mechanism of Gene-Environment Interactions Driving Glial Activation in Parkinson's Diseases.

Authors:  Souvarish Sarkar
Journal:  Curr Environ Health Rep       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.